{"id":7100,"date":"2023-07-29T07:06:00","date_gmt":"2023-07-29T14:06:00","guid":{"rendered":"https:\/\/allocare.caredx.com\/?p=7100"},"modified":"2023-07-27T07:09:39","modified_gmt":"2023-07-27T14:09:39","slug":"transplant-may-be-reasonable-for-certain-crc-patients-with-liver-mets","status":"publish","type":"post","link":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/07\/29\/transplant-may-be-reasonable-for-certain-crc-patients-with-liver-mets\/","title":{"rendered":"Transplant May Be Reasonable for Certain CRC Patients With Liver Mets"},"content":{"rendered":"<span class=\"simplefavorite-button has-count loading\" data-postid=\"7100\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"1\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>\n<h2 class=\"wp-block-heading\"><em>\u2014 OS rates could be over 80% depending on clinical predictive factors<\/em><\/h2>\n\n\n\n<p>By Mike Bassett<\/p>\n\n\n\n<p>For a select group of patients with colorectal cancer and unresectable liver metastases, liver transplant may be a reasonable option, according to results from a prospective, nonrandomized controlled cohort study.<\/p>\n\n\n\n<p>Overall, among 61 patients who underwent liver transplant, the median disease-free survival (DFS) was 11.8 months (95% CI 9.3-14.2), with a 5-year DFS rate of 18.3%, and the median overall survival (OS) was 60.3 months (95% CI 44.3-76.4), with a 5-year OS rate of 50.4%, reported Svein Dueland, MD, PhD, of Oslo University Hospital in Norway, and colleagues. <a href=\"https:\/\/www.medpagetoday.com\/hematologyoncology\/coloncancer\/105649\">Read the full article in MedPage Today.<\/a><\/p>\n<span class=\"simplefavorite-button has-count loading\" data-postid=\"7100\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"1\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>","protected":false},"excerpt":{"rendered":"<p>Loading \u2014 OS rates could be over 80% depending on clinical predictive factors By Mike Bassett For a select group of patients with colorectal cancer and unresectable liver metastases, liver &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/07\/29\/transplant-may-be-reasonable-for-certain-crc-patients-with-liver-mets\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Transplant May Be Reasonable for Certain CRC Patients With Liver Mets&#8221;<\/span><\/a><\/p>\n","protected":false},"author":208,"featured_media":3809,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","_ecp_custom_2":"","footnotes":""},"categories":[45,7],"tags":[2151,172],"post_format":[],"Dislikes":"","Likes":"","simplefavorites_count":"1","views":"1114","post_likes_plusCounter":"1","post_dislikes_plusCounter":"","acf":[],"_links":{"self":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/7100"}],"collection":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/users\/208"}],"replies":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/comments?post=7100"}],"version-history":[{"count":1,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/7100\/revisions"}],"predecessor-version":[{"id":7101,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/7100\/revisions\/7101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media\/3809"}],"wp:attachment":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media?parent=7100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/categories?post=7100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/tags?post=7100"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/post_format?post=7100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}